The global fight against tuberculosis (TB) has reached a pivotal juncture, with the World Health Organization (WHO) unveiling transformative new…
Read More
Breath-based VOC Analysis Offers Faster, Non-invasive Assessment of Gut Microbiome Health and Earlier Disease Detection
A groundbreaking study conducted by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
Terray’s TerraBind Delivers 26x Faster Inference and Enhanced Accuracy, Challenging Diffusion-Based AI Models in Drug Discovery
In a significant development poised to reshape the landscape of AI-driven drug discovery, Terray Therapeutics, a Los Angeles-based startup, has…
Read More
WHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.
The World Health Organization (WHO) has unveiled a set of groundbreaking new recommendations designed to revolutionize tuberculosis (TB) diagnostics, emphasizing…
Read More
Breath-based VOC analysis could give clinical labs a faster, noninvasive way to assess gut microbiome health and detect disease earlier.
The landscape of clinical diagnostics is on the cusp of a significant transformation, with new research pointing towards a rapid,…
Read More
Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
Terray Therapeutics, a burgeoning startup based in the Los Angeles area, has unveiled TerraBind, a groundbreaking potency prediction model designed…
Read More
Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
In a significant development for AI-driven drug discovery, Terray Therapeutics, a Los Angeles-area startup, has introduced TerraBind, a novel potency…
Read More
